HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is grand multiparity associated with an increased risk of dysglycaemia?

AbstractAIMS/HYPOTHESIS:
We sought to determine the risk of diabetes and IGT/IFG with grand multiparity.
SUBJECTS, MATERIALS AND METHODS:
Women, aged > or =25 years, from the Australian Diabetes, Obesity and Lifestyle Study and the Crossroads Undiagnosed Disease Study (a rural study in Victoria, Australia), participated in a household census (response 67 and 70%, respectively), subsequently attending a biomedical examination that included an oral glucose tolerance test (58% [6198] and 69% [819]).
RESULTS:
After adjusting for age, obesity and socio-economic status, diabetes, but not IGT/IFG, was less common among women with a parity of 1 to 2 (odds ratio [OR]=0.64 [0.48-0.84]) and 3 to 4 (OR=0.72 [0.53-0.96]) than in grand multiparous women. This relationship was unrelated to past hysterectomy, use of the oral contraceptive pill or menopausal status.
CONCLUSIONS/INTERPRETATION:
Grand multiparity is associated with an increased risk of diabetes but not of IGT/IFG. We postulate that parity accelerates transition from IGT/IFG to diabetes, more than it does transition from normal glucose tolerance to IGT/IFG.
AuthorsD Simmons, J Shaw, A McKenzie, S Eaton, A J Cameron, P Zimmet
JournalDiabetologia (Diabetologia) Vol. 49 Issue 7 Pg. 1522-7 (Jul 2006) ISSN: 0012-186X [Print] Germany
PMID16752170 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Contraceptive Agents, Female
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Australia
  • Blood Glucose (analysis)
  • Case-Control Studies
  • Contraceptive Agents, Female (adverse effects)
  • Diabetes Mellitus (blood, etiology)
  • Diabetes, Gestational (epidemiology)
  • Female
  • Glucose Intolerance (etiology)
  • Glucose Tolerance Test
  • Health Surveys
  • Humans
  • Hysterectomy (adverse effects)
  • Middle Aged
  • Parity
  • Postmenopause (blood)
  • Pregnancy
  • Random Allocation
  • Risk Factors
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: